The UK is establishing an AI biosecurity lab with £100 million in government funding and up to £200 million in compute credits, model access and technical support from OpenAI and Anthropic

The UK is establishing an AI biosecurity lab with £100 million in government funding and up to £200 million in compute credits, model access and technical support from OpenAI and Anthropic

On 24 October, the UK Cabinet Office announced the creation of the AI Biosecurity Lab (AIBL), an independent nonprofit organization established as part of the national AI and biosecurity initiative. Its initial priorities are to detect biological threats earlier and accelerate the development, validation and testing of vaccines, medicines and other countermeasures.

The national initiative allocates £165 million as follows: £100 million for AIBL and a further £65 million for biological threat surveillance and the development of vaccines, medicines and other countermeasures. OpenAI will provide the lab with £100 million in compute credits and access to its models. Anthropic will contribute up to £100 million in credits, model access and technical support.

Through Rosalind Biodefense, AIBL will receive trusted access to GPT-Rosalind, OpenAI’s biology model, which is available to qualified organizations through this program. The lab will work with UK public health, animal health and plant health agencies, the Defence Science and Technology Laboratory and the medicines regulator. Google DeepMind and Basecamp Research are named as research partners.

The decision reflects the dual role of current models: they accelerate biological research while also lowering the barriers to harmful work with pathogens. AIBL is intended to integrate models and computing resources into the work of agencies responsible for threat surveillance, preparedness for public health emergencies and the regulation of medicines designed using AI.